These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26573009)

  • 1. Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.
    Rosano C; Ponassi M; Santolla MF; Pisano A; Felli L; Vivacqua A; Maggiolini M; Lappano R
    AAPS J; 2016 Jan; 18(1):41-6. PubMed ID: 26573009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Approaches for the Discovery of GPER Targeting Compounds.
    Grande F; Occhiuzzi MA; Lappano R; Cirillo F; Guzzi R; Garofalo A; Jacquot Y; Maggiolini M; Rizzuti B
    Front Endocrinol (Lausanne); 2020; 11():517. PubMed ID: 32849301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1).
    Bruno A; Aiello F; Costantino G; Radi M
    Mol Inform; 2016 Sep; 35(8-9):333-9. PubMed ID: 27546037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the rationale design of GPER ligands.
    Rosano C; Lappano R; Santolla MF; Ponassi M; Donadini A; Maggiolini M
    Curr Med Chem; 2012; 19(36):6199-206. PubMed ID: 23116143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.
    Barton M; Filardo EJ; Lolait SJ; Thomas P; Maggiolini M; Prossnitz ER
    J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.
    Méndez-Luna D; Martínez-Archundia M; Maroun RC; Ceballos-Reyes G; Fragoso-Vázquez MJ; González-Juárez DE; Correa-Basurto J
    J Biomol Struct Dyn; 2015; 33(10):2161-72. PubMed ID: 25587872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen biology: new insights into GPER function and clinical opportunities.
    Prossnitz ER; Barton M
    Mol Cell Endocrinol; 2014 May; 389(1-2):71-83. PubMed ID: 24530924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models.
    Lappano R; Rosano C; Pisano A; Santolla MF; De Francesco EM; De Marco P; Dolce V; Ponassi M; Felli L; Cafeo G; Kohnke FH; Abonante S; Maggiolini M
    Dis Model Mech; 2015 Oct; 8(10):1237-46. PubMed ID: 26183213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER modulators: Opportunity Nox on the heels of a class Akt.
    Prossnitz ER
    J Steroid Biochem Mol Biol; 2018 Feb; 176():73-81. PubMed ID: 28285016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.
    Prossnitz ER; Arterburn JB
    Pharmacol Rev; 2015 Jul; 67(3):505-40. PubMed ID: 26023144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.
    Sinicropi MS; Lappano R; Caruso A; Santolla MF; Pisano A; Rosano C; Capasso A; Panno A; Lancelot JC; Rault S; Saturnino C; Maggiolini M
    Curr Top Med Chem; 2015; 15(11):1035-42. PubMed ID: 25786510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M; Wolber G
    Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G-protein coupled estrogen receptor, GPER: The inside and inside-out story.
    Gaudet HM; Cheng SB; Christensen EM; Filardo EJ
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():207-19. PubMed ID: 26190834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.
    Heifetz A; Southey M; Morao I; Townsend-Nicholson A; Bodkin MJ
    Methods Mol Biol; 2018; 1705():375-394. PubMed ID: 29188574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled estrogen receptor-1: homology modeling approaches and application in screening new GPER-1 modulators.
    Khan SU; Ahemad N; Chuah LH; Naidu R; Htar TT
    J Biomol Struct Dyn; 2022 Apr; 40(7):3325-3335. PubMed ID: 33164654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.